Trial for reduction of anxiety and fatigue -open study- - Trial for reduction of anxiety and fatigue

IMEQRD inc.0 sites20 target enrollmentJanuary 13, 2022

Overview

No summary available.

Registry

who.int

Start Date

January 13, 2022

End Date

March 2, 2021

Last Updated

2 years ago

Study Type

Interventional

Sex

Female

Sponsor

IMEQRD inc.

•Subjects who 1\.are currently receiving any types of medicines and/or Chinese medical treatment (except for the drugs taken as needed). 2\.plan to change their lifestyle during the test. 3\.have a serious illness such as liver, kidney, heart, respiratory tract, endocrine, metabolic disease, etc.. 4\.are receiving treatment for mental illness such as depression or anxiety disorder, or have a history of it. 5\.May take sleeping pills/ sleep\-inducing drugs during the test period, continuously or when they need. 6\.Have been diagnosed with chronic fatigue syndrome. 7\.Have had life events that affect their mind and body such as loss of important things within one month (death of relatives, loss of employment, divorce, pet death). 8\.Take healthy foods or supplements daily. (acceptable if they can stop taking after obtaining consent.) 9\.have a past and current medical history of drug or food allergy. 10\.have participated in other clinical trials within one month before obtaining consent, or those who plan to participate during the trial period. 11\.consume alcohol excessively (alcohol equivalent 60g or more / day). 12\.have smoking habit. 13\.have an irregular diet, or irregular life rhythms (work in shifts, work late at night etc.). 14\.are judged by the investigator to be unsuitable for participating in this study.